| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.706 | 0.002 | 0.706 | Dopamine transporter inhibitor | 0.603 0.002 CID_66971611 | ||
| 0.659 | 0.003 | 0.659 | Adrenaline uptake inhibitor | 0.565 0.003 CID_66971611 | ||
| 0.614 | 0.005 | 0.614 | Psychostimulant | 0.59 0.006 CID_66971611 | ||
| 0.6 | 0.004 | 0.6 | 5 Hydroxytryptamine uptake inhibitor | 0.476 0.004 CID_66971611 | ||
| 0.497 | 0.028 | 0.605 | Vasodilator, peripheral | 0.605 0.015 CID_66971611 | CID_66971611 | |
| 0.436 | 0.039 | 0.452 | 5 Hydroxytryptamine release stimulant | 0.452 0.036 CID_66971611 | CID_66971611 | |
| 0.365 | 0.022 | 0.365 | 5 Hydroxytryptamine uptake stimulant | 0.352 0.025 CID_66971611 | ||
| 0.347 | 0.009 | 0.347 | Anesthetic local | 0.328 0.01 CID_66971611 | ||
| 0.421 | 0.083 | 0.421 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | |||
| 0.34 | 0.025 | 0.34 | Anesthetic general | 0.328 0.027 CID_66971611 | ||
| 0.322 | 0.024 | 0.322 | Tyrosine 3 hydroxylase inhibitor | 0.308 0.03 CID_66971611 | ||
| 0.384 | 0.089 | 0.384 | 5 Hydroxytryptamine release inhibitor | 0.295 0.171 CID_66971611 | ||
| 0.301 | 0.048 | 0.341 | Vasodilator | 0.341 0.036 CID_66971611 | CID_66971611 | |
| 0.317 | 0.075 | 0.317 | Calcium channel activator | 0.295 0.096 CID_66971611 | ||
| 0.259 | 0.034 | 0.281 | Neurotrophic factor enhancer | 0.281 0.024 CID_66971611 | CID_66971611 | |
| 0.222 | 0.003 | 0.222 | Nicotinic alpha3beta2 receptor antagonist | 0.154 0.004 CID_66971611 | ||
| 0.27 | 0.057 | 0.27 | Gastrin inhibitor | 0.228 0.108 CID_66971611 | ||
| 0.203 | 0.006 | 0.203 | Dopamine uptake inhibitor | 0.137 0.012 CID_66971611 | ||
| 0.242 | 0.053 | 0.267 | DNA methylase inhibitor | 0.267 0.04 CID_66971611 | CID_66971611 | |
| 0.285 | 0.096 | 0.363 | Apoptosis antagonist | 0.363 0.05 CID_66971611 | CID_66971611 | |
| 0.186 | 0.005 | 0.186 | Nicotinic alpha4beta2 receptor antagonist | 0.142 0.009 CID_66971611 | ||
| 0.177 | 0.005 | 0.177 | Nicotinic receptor alpha3 subunit antagonist | 0.096 0.01 CID_66971611 | ||
| 0.277 | 0.106 | 0.463 | Cholesterol antagonist | 0.463 0.038 CID_66971611 | CID_66971611 | |
| 0.275 | 0.109 | 0.324 | Vasodilator, coronary | 0.324 0.069 CID_66971611 | CID_66971611 | |
| 0.242 | 0.08 | 0.242 | Superoxide dismutase inhibitor | 0.217 0.1 CID_66971611 | ||
| 0.187 | 0.026 | 0.187 | Antibacterial (Helicobacter pylori) | 0.183 0.027 CID_66971611 | ||
| 0.248 | 0.092 | 0.326 | Spasmolytic | 0.326 0.06 CID_66971611 | CID_66971611 | |
| 0.238 | 0.088 | 0.238 | 5 Hydroxytryptamine 1E antagonist | |||
| 0.166 | 0.017 | 0.166 | Ca2+-transporting ATPase inhibitor | 0.157 0.028 CID_66971611 | ||
| 0.269 | 0.138 | 0.269 | GABA C receptor rho-3 antagonist | |||
| 0.197 | 0.067 | 0.197 | 5 Hydroxytryptamine 3E antagonist | |||
| 0.292 | 0.164 | 0.429 | Calcium channel L-type activator | 0.429 0.062 CID_66971611 | CID_66971611 | |
| 0.148 | 0.021 | 0.148 | Acetylcholine nicotinic antagonist | 0.141 0.023 CID_66971611 | ||
| 0.18 | 0.063 | 0.18 | MAP kinase kinase 5 inhibitor | 0.164 0.103 CID_66971611 | ||
| 0.213 | 0.098 | 0.213 | Neuropeptide Y2 antagonist | 0.178 0.164 CID_66971611 | ||
| 0.176 | 0.065 | 0.176 | Heat shock protein 90 alpha antagonist | |||
| 0.117 | 0.009 | 0.117 | CC chemokine 5 receptor agonist | 0.082 0.058 CID_66971611 | ||
| 0.155 | 0.049 | 0.155 | Nav1.6 sodium channel blocker | 0.127 0.086 CID_66971611 | ||
| 0.139 | 0.033 | 0.139 | Sphingosine 1-phosphate receptor 2 agonist | 0.118 0.058 CID_66971611 | ||
| 0.156 | 0.051 | 0.156 | Sphingosine 1-phosphate receptor 5 antagonist | 0.137 0.086 CID_66971611 | ||
| 0.119 | 0.018 | 0.119 | Neuronal nicotinic receptor antagonist | 0.114 0.019 CID_66971611 | ||
| 0.154 | 0.053 | 0.289 | Alpha-N-acetylglucosaminidase inhibitor | 0.289 0.017 CID_66971611 | CID_66971611 | |
| 0.147 | 0.045 | 0.147 | Sphingosine 1-phosphate receptor 2 antagonist | 0.142 0.052 CID_66971611 | ||
| 0.104 | 0.006 | 0.104 | Nicotinic receptor beta4 subunit antagonist | 0.087 0.007 CID_66971611 | ||
| 0.165 | 0.07 | 0.165 | Neurotensin receptor agonist | 0.152 0.096 CID_66971611 | ||
| 0.222 | 0.127 | 0.222 | Insulysin inhibitor | |||
| 0.131 | 0.038 | 0.131 | Antihistaminic | 0.089 0.066 CID_66971611 | ||
| 0.133 | 0.041 | 0.133 | Nav1.1 sodium channel blocker | 0.132 0.041 CID_66971611 | ||
| 0.119 | 0.031 | 0.134 | Lanosterol 14 alpha demethylase inhibitor | 0.134 0.019 CID_66971611 | CID_66971611 | |
| 0.125 | 0.038 | 0.125 | Creatine kinase inhibitor | 0.103 0.057 CID_66971611 | ||
| 0.133 | 0.046 | 0.133 | Ferrochelatase inhibitor | |||
| 0.143 | 0.057 | 0.157 | Cholinergic antagonist | 0.157 0.049 CID_66971611 | CID_66971611 | |
| 0.149 | 0.063 | 0.149 | Toll-Like receptor 9 antagonist | |||
| 0.146 | 0.06 | 0.146 | Nav1.2 sodium channel blocker | |||
| 0.121 | 0.038 | 0.121 | Histamine antagonist | 0.078 0.066 CID_66971611 | ||
| 0.092 | 0.01 | 0.092 | Nicotinic receptor alpha4 subunit antagonist | 0.072 0.016 CID_66971611 | ||
| 0.106 | 0.024 | 0.181 | Interferon agonist | 0.181 0.007 CID_66971611 | CID_66971611 | |
| 0.138 | 0.057 | 0.151 | Acetylcholine antagonist | 0.151 0.049 CID_66971611 | CID_66971611 | |
| 0.168 | 0.088 | 0.182 | DNA methyltransferase I inhibitor | 0.182 0.079 CID_66971611 | CID_66971611 | |
| 0.158 | 0.079 | 0.158 | Arachidonic acid antagonist | 0.14 0.1 CID_66971611 | ||
| 0.095 | 0.018 | 0.095 | Phospholipase D inhibitor | 0.077 0.039 CID_66971611 | ||
| 0.184 | 0.107 | 0.188 | Cyclic AMP phosphodiesterase inhibitor | 0.188 0.103 CID_66971611 | CID_66971611 | |
| 0.127 | 0.049 | 0.13 | Falcipain 3 inhibitor | 0.13 0.047 CID_66971611 | CID_66971611 | |
| 0.092 | 0.015 | 0.092 | Potassium channel (Tandem pore domain) blocker | |||
| 0.079 | 0.004 | 0.079 | p53 inhibitor | 0.073 0.005 CID_66971611 | ||
| 0.141 | 0.067 | 0.169 | Neurotrophic factor | 0.169 0.044 CID_66971611 | CID_66971611 | |
| 0.078 | 0.005 | 0.09 | GABA uptake inhibitor | 0.09 0.004 CID_66971611 | CID_66971611 | |
| 0.115 | 0.042 | 0.157 | Prolactin inhibitor | 0.157 0.019 CID_66971611 | CID_66971611 | |
| 0.256 | 0.183 | 0.256 | MAP kinase kinase 6 inhibitor | |||
| 0.162 | 0.091 | 0.171 | Succinate dehydrogenase inhibitor | 0.171 0.079 CID_66971611 | CID_66971611 | |
| 0.096 | 0.026 | 0.096 | Dopamine D3 antagonist | |||
| 0.283 | 0.213 | 0.357 | Caspase 9 stimulant | 0.357 0.14 CID_66971611 | CID_66971611 | |
| 0.184 | 0.114 | 0.184 | Aldehyde oxidase inhibitor | 0.164 0.127 CID_66971611 | ||
| 0.123 | 0.055 | 0.123 | TRPA1 agonist | |||
| 0.155 | 0.089 | 0.155 | Antipruritic | |||
| 0.129 | 0.064 | 0.129 | Nav1.3 sodium channel blocker | 0.113 0.082 CID_66971611 | ||
| 0.142 | 0.078 | 0.176 | Hemostatic | 0.176 0.045 CID_66971611 | CID_66971611 | |
| 0.128 | 0.065 | 0.128 | Cathepsin H inhibitor | |||
| 0.121 | 0.058 | 0.121 | Transcription factor STAT6 inhibitor | |||
| 0.104 | 0.042 | 0.104 | Histamine N-methyltransferase inhibitor | |||
| 0.078 | 0.017 | 0.078 | Histamine H3 receptor antagonist | 0.038 0.036 CID_66971611 | ||
| 0.079 | 0.018 | 0.079 | Corticotropin releasing factor 2 receptor antagonist | |||
| 0.116 | 0.056 | 0.116 | Acetylcholine release stimulant | |||
| 0.23 | 0.171 | 0.23 | Histamine release inhibitor | 0.213 0.188 CID_66971611 | ||
| 0.128 | 0.07 | 0.135 | Vanilloid 1 agonist | 0.135 0.057 CID_66971611 | CID_66971611 | |
| 0.09 | 0.033 | 0.09 | Viral attachment inhibitor | 0.083 0.044 CID_66971611 | ||
| 0.063 | 0.006 | 0.063 | Delayed rectifier potassium channel blocker | 0.047 0.013 CID_66971611 | ||
| 0.073 | 0.016 | 0.073 | CC chemokine 5 receptor antagonist | 0.058 0.028 CID_66971611 | ||
| 0.143 | 0.087 | 0.143 | Interferon gamma antagonist | 0.137 0.098 CID_66971611 | ||
| 0.083 | 0.032 | 0.083 | Acetylcholine M5 receptor agonist | |||
| 0.113 | 0.062 | 0.113 | 5 Hydroxytryptamine 3A agonist | |||
| 0.093 | 0.042 | 0.106 | mTOR complex 2 inhibitor | 0.106 0.027 CID_66971611 | CID_66971611 | |
| 0.087 | 0.036 | 0.087 | Aminopeptidase I inhibitor | 0.079 0.043 CID_66971611 | ||
| 0.15 | 0.101 | 0.15 | ATPase inhibitor | |||
| 0.104 | 0.055 | 0.168 | Sphingomyelinase inhibitor | 0.168 0.018 CID_66971611 | CID_66971611 | |
| 0.116 | 0.067 | 0.127 | Caspase 3 inhibitor | 0.127 0.05 CID_66971611 | CID_66971611 | |
| 0.09 | 0.042 | 0.178 | Catalase inhibitor | 0.178 0.02 CID_66971611 | CID_66971611 | |
| 0.064 | 0.017 | 0.064 | Squalene epoxidase inhibitor | 0.062 0.019 CID_66971611 | ||
| 0.051 | 0.005 | 0.051 | Adenosine uptake inhibitor | |||
| 0.105 | 0.062 | 0.109 | GABA C receptor agonist | 0.109 0.058 CID_66971611 | CID_66971611 | |
| 0.074 | 0.032 | 0.078 | Protease 3C (Human rhinovirus) inhibitor | 0.078 0.029 CID_66971611 | CID_66971611 | |
| 0.086 | 0.044 | 0.086 | Dopamine antagonist | |||
| 0.052 | 0.011 | 0.052 | Heme oxygenase inhibitor | 0.047 0.017 CID_66971611 | ||
| 0.098 | 0.056 | 0.145 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.145 0.028 CID_66971611 | CID_66971611 | |
| 0.069 | 0.028 | 0.069 | Potassium channel intermediate-conductance Ca-activated blocker | |||
| 0.208 | 0.167 | 0.303 | Antithrombotic | 0.303 0.086 CID_66971611 | CID_66971611 | |
| 0.083 | 0.043 | 0.083 | GABA aminotransferase inhibitor | 0.072 0.059 CID_66971611 | ||
| 0.058 | 0.019 | 0.058 | Cholesterol esterase inhibitor | 0.058 0.02 CID_66971611 | ||
| 0.079 | 0.04 | 0.079 | Glycine receptor agonist | 0.071 0.052 CID_66971611 | ||
| 0.054 | 0.017 | 0.058 | Guanylate cyclase inhibitor | 0.058 0.014 CID_66971611 | CID_66971611 | |
| 0.087 | 0.05 | 0.087 | Histamine H1 receptor antagonist | |||
| 0.178 | 0.142 | 0.274 | Interleukin agonist | 0.274 0.063 CID_66971611 | CID_66971611 | |
| 0.067 | 0.032 | 0.087 | Argininosuccinate synthase inhibitor | 0.087 0.023 CID_66971611 | CID_66971611 | |
| 0.117 | 0.083 | 0.209 | Amylase inhibitor | 0.209 0.041 CID_66971611 | CID_66971611 | |
| 0.071 | 0.036 | 0.081 | MDM2 inhibitor | 0.081 0.019 CID_66971611 | CID_66971611 | |
| 0.062 | 0.027 | 0.062 | Nicotinic receptor alpha7 subunit antagonist | 0.059 0.029 CID_66971611 | ||
| 0.131 | 0.097 | 0.131 | Heat shock protein 90 antagonist | |||
| 0.209 | 0.175 | 0.358 | Interleukin 2 agonist | 0.358 0.042 CID_66971611 | CID_66971611 | |
| 0.059 | 0.025 | 0.059 | 5 Hydroxytryptamine 4 antagonist | 0.049 0.04 CID_66971611 | ||
| 0.097 | 0.064 | 0.146 | UDP-glucose 4-epimerase inhibitor | 0.146 0.03 CID_66971611 | CID_66971611 | |
| 0.11 | 0.078 | 0.11 | Calcium channel N-type blocker | |||
| 0.08 | 0.049 | 0.08 | Estrogen receptor alpha antagonist | 0.073 0.061 CID_66971611 | ||
| 0.057 | 0.027 | 0.057 | Prolyl endopeptidase inhibitor | 0.057 0.027 CID_66971611 | ||
| 0.087 | 0.057 | 0.087 | Calcium antagonist | |||
| 0.076 | 0.047 | 0.101 | Cathepsin G inhibitor | 0.101 0.033 CID_66971611 | CID_66971611 | |
| 0.13 | 0.1 | 0.13 | Neuropeptide Y1 antagonist | |||
| 0.121 | 0.092 | 0.19 | Protein kinase stimulant | 0.19 0.045 CID_66971611 | CID_66971611 | |
| 0.117 | 0.089 | 0.117 | Papain-like protease (SARS coronavirus) inhibitor | |||
| 0.087 | 0.058 | 0.116 | Granulocyte macrophage colony stimulating factor agonist | 0.116 0.018 CID_66971611 | CID_66971611 | |
| 0.053 | 0.026 | 0.053 | CC chemokine receptor 2B antagonist | |||
| 0.035 | 0.009 | 0.035 | Estrogen-related receptor gamma antagonist | 0.03 0.015 CID_66971611 | ||
| 0.088 | 0.063 | 0.123 | Triose-phosphate isomerase inhibitor | 0.123 0.03 CID_66971611 | CID_66971611 | |
| 0.063 | 0.039 | 0.063 | TRPA1 antagonist | |||
| 0.066 | 0.042 | 0.098 | Interferon inducer | 0.098 0.013 CID_66971611 | CID_66971611 | |
| 0.05 | 0.027 | 0.05 | Benzodiazepine antagonist | |||
| 0.112 | 0.089 | 0.112 | Sphingosine 1-phosphate receptor 4 antagonist | 0.11 0.093 CID_66971611 | ||
| 0.064 | 0.041 | 0.064 | Calcium channel P-type blocker | |||
| 0.03 | 0.009 | 0.03 | Acid ceramidase inhibitor | 0.026 0.017 CID_66971611 | ||
| 0.132 | 0.111 | 0.132 | Melanin inhibitor | 0.127 0.121 CID_66971611 | ||
| 0.082 | 0.062 | 0.082 | Estrogen-related receptor beta agonist | |||
| 0.06 | 0.041 | 0.06 | Phosphodiesterase 1A inhibitor | |||
| 0.071 | 0.053 | 0.079 | Glutamate decarboxylase inhibitor | 0.079 0.045 CID_66971611 | CID_66971611 | |
| 0.039 | 0.022 | 0.039 | 2,3-Oxidosqualene-lanosterol cyclase inhibitor | |||
| 0.078 | 0.06 | 0.078 | Glycine receptor antagonist | |||
| 0.089 | 0.072 | 0.089 | Alpha 2d adrenoreceptor antagonist | |||
| 0.054 | 0.038 | 0.054 | Myc inhibitor | |||
| 0.022 | 0.007 | 0.022 | CXC chemokine 5 receptor antagonist | 0.017 0.014 CID_66971611 | ||
| 0.035 | 0.022 | 0.035 | CDK6/cyclin D3 inhibitor | |||
| 0.057 | 0.045 | 0.057 | Cyclin-dependent kinase 6 inhibitor | |||
| 0.09 | 0.079 | 0.091 | Anabolic | 0.091 0.076 CID_66971611 | CID_66971611 | |
| 0.068 | 0.057 | 0.068 | Epoxide hydrolase inhibitor | |||
| 0.043 | 0.032 | 0.043 | Glutamate (mGluR4) antagonist | 0.04 0.037 CID_66971611 | ||
| 0.036 | 0.025 | 0.036 | Kainate receptor 2 antagonist | |||
| 0.024 | 0.013 | 0.024 | Protease (Human cytomegalovirus) inhibitor | |||
| 0.124 | 0.114 | 0.137 | Adenylate cyclase stimulant | 0.137 0.086 CID_66971611 | CID_66971611 | |
| 0.099 | 0.089 | 0.099 | Cholesterol synthesis inhibitor | |||
| 0.037 | 0.028 | 0.037 | Potassium channel Kv1.1 blocker | |||
| 0.179 | 0.17 | 0.179 | Transcription factor STAT inhibitor | |||
| 0.025 | 0.016 | 0.025 | 5 Hydroxytryptamine 4 agonist | |||
| 0.052 | 0.043 | 0.09 | Sphingosine kinase 2 inhibitor | 0.09 0.011 CID_66971611 | CID_66971611 | |
| 0.088 | 0.08 | 0.088 | Bile acid receptor antagonist | |||
| 0.023 | 0.015 | 0.023 | Corticotropin releasing factor 1 receptor antagonist | |||
| 0.027 | 0.02 | 0.027 | Histamine H3 receptor agonist | |||
| 0.021 | 0.014 | 0.021 | Histone-lysine N-methyltransferase EZH2 inhibitor | |||
| 0.07 | 0.063 | 0.072 | Vanilloid 4 agonist | 0.072 0.058 CID_66971611 | CID_66971611 | |
| 0.034 | 0.027 | 0.059 | Ceramide glucosyltransferase inhibitor | 0.059 0.004 CID_66971611 | CID_66971611 | |
| 0.038 | 0.031 | 0.038 | AMPA 4 receptor antagonist | |||
| 0.038 | 0.032 | 0.038 | CDK5/p25 inhibitor | |||
| 0.025 | 0.019 | 0.025 | Vanilloid 2 agonist | |||
| 0.028 | 0.023 | 0.028 | Peptide deformylase inhibitor | |||
| 0.042 | 0.037 | 0.049 | Glycine transporter 2 inhibitor | 0.049 0.031 CID_66971611 | CID_66971611 | |
| 0.038 | 0.034 | 0.038 | Oxytocin agonist | |||
| 0.076 | 0.071 | 0.076 | Caspase 7 inhibitor | |||
| 0.103 | 0.099 | 0.161 | Toll-Like receptor 2 antagonist | 0.161 0.045 CID_66971611 | CID_66971611 | |
| 0.013 | 0.009 | 0.013 | Cyclin D2 inhibitor | |||
| 0.139 | 0.135 | 0.139 | P-glycoprotein inhibitor | 0.138 0.137 CID_66971611 | ||
| 0.009 | 0.006 | 0.009 | Corticotropin releasing factor antagonist | |||
| 0.055 | 0.052 | 0.055 | NMDA 2C receptor antagonist | |||
| 0.038 | 0.035 | 0.038 | Acetylcholine M1 receptor agonist | |||
| 0.075 | 0.072 | 0.075 | NMDA receptor antagonist | |||
| 0.036 | 0.034 | 0.036 | Dopamine D5 agonist | |||
| 0.137 | 0.135 | 0.179 | Phospholipase C inhibitor | 0.179 0.062 CID_66971611 | CID_66971611 | |
| 0.04 | 0.039 | 0.04 | Glutamate (mGluR group III) antagonist | |||
| 0.03 | 0.029 | 0.03 | Estrogen-related receptor beta antagonist | |||
| 0.107 | 0.108 | 0.111 | Toll-Like receptor antagonist | 0.111 0.1 CID_66971611 | CID_66971611 | |
| 0.071 | 0.077 | 0.076 | MAP kinase kinase 7 inhibitor | 0.076 0.059 CID_66971611 | CID_66971611 | |
| 0.076 | 0.084 | 0.151 | HIV-1 integrase (Overall Integration) inhibitor | 0.151 0.025 CID_66971611 | CID_66971611 | |
| 0.059 | 0.069 | 0.064 | Glutamate (mGluR6) antagonist | 0.064 0.055 CID_66971611 | CID_66971611 | |
| 0.035 | 0.046 | 0.043 | Angiotensin AT1 receptor antagonist | 0.043 0.028 CID_66971611 | CID_66971611 | |
| 0.05 | 0.062 | 0.078 | Sphingosine kinase inhibitor | 0.078 0.017 CID_66971611 | CID_66971611 | |
| 0.054 | 0.069 | 0.058 | Phosphodiesterase 1C inhibitor | 0.058 0.055 CID_66971611 | CID_66971611 | |
| 0.089 | 0.105 | 0.096 | Acetylcholine muscarinic antagonist | 0.096 0.095 CID_66971611 | CID_66971611 | |
| 0.042 | 0.058 | 0.054 | Cytokine production stimulant | 0.054 0.021 CID_66971611 | CID_66971611 | |
| 0.033 | 0.051 | 0.052 | Sphingosine kinase 1 inhibitor | 0.052 0.014 CID_66971611 | CID_66971611 | |
| 0.045 | 0.066 | 0.051 | Sphingosine 1-phosphate receptor 5 agonist | 0.051 0.043 CID_66971611 | CID_66971611 | |
| 0.056 | 0.077 | 0.071 | Prolactin release inhibitor | 0.071 0.02 CID_66971611 | CID_66971611 | |
| 0.131 | 0.154 | 0.157 | Anticonvulsant | 0.157 0.121 CID_66971611 | CID_66971611 | |
| 0.025 | 0.049 | 0.032 | Angiotensin II receptor antagonist | 0.032 0.027 CID_66971611 | CID_66971611 | |
| 0.139 | 0.164 | 0.256 | Immunostimulant | 0.256 0.094 CID_66971611 | CID_66971611 | |
| 0.034 | 0.061 | 0.048 | Ornithine carbamoyltransferase inhibitor | 0.048 0.041 CID_66971611 | CID_66971611 | |
| 0.075 | 0.105 | 0.098 | Interleukin 1 beta converting enzyme inhibitor | 0.098 0.06 CID_66971611 | CID_66971611 | |
| 0.039 | 0.073 | 0.068 | Alpha-mannosidase inhibitor | 0.068 0.018 CID_66971611 | CID_66971611 | |
| 0.05 | 0.084 | 0.092 | Porphobilinogen synthase inhibitor | 0.092 0.04 CID_66971611 | CID_66971611 | |
| 0.035 | 0.072 | 0.048 | Glucose-6-phosphate isomerase inhibitor | 0.048 0.033 CID_66971611 | CID_66971611 | |
| 0.039 | 0.079 | 0.059 | Carbamoyl phosphate synthetase inhibitor | 0.059 0.044 CID_66971611 | CID_66971611 | |
| 0.025 | 0.072 | 0.056 | Adenosine deaminase inhibitor | 0.056 0.024 CID_66971611 | CID_66971611 | |
| 0.153 | 0.201 | 0.171 | Nitric-oxide synthase stimulant | 0.171 0.149 CID_66971611 | CID_66971611 | |
| 0.077 | 0.129 | 0.092 | Adenylate kinase inhibitor | 0.092 0.083 CID_66971611 | CID_66971611 | |
| 0.095 | 0.149 | 0.136 | Cell wall synthesis inhibitor | 0.136 0.079 CID_66971611 | CID_66971611 | |
| 0.052 | 0.107 | 0.081 | Ornithine decarboxylase inhibitor | 0.081 0.066 CID_66971611 | CID_66971611 | |
| 0.094 | 0.155 | 0.114 | DNA repair enzyme inhibitor | 0.114 0.085 CID_66971611 | CID_66971611 | |
| 0.063 | 0.125 | 0.083 | NADH dehydrogenase inhibitor | 0.083 0.069 CID_66971611 | CID_66971611 | |
| 0.08 | 0.144 | 0.106 | Aldehyde dehydrogenase inhibitor | 0.106 0.088 CID_66971611 | CID_66971611 | |
| 0.024 | 0.09 | 0.054 | Mannosidase inhibitor | 0.054 0.021 CID_66971611 | CID_66971611 | |
| 0.037 | 0.104 | 0.06 | Glucosylceramidase inhibitor | 0.06 0.031 CID_66971611 | CID_66971611 | |
| 0.069 | 0.144 | 0.106 | Mucolytic | 0.106 0.07 CID_66971611 | CID_66971611 | |
| 0.033 | 0.109 | 0.064 | Phosphofructokinase-1 inhibitor | 0.064 0.052 CID_66971611 | CID_66971611 | |
| 0.068 | 0.148 | 0.088 | Glutamate release inhibitor | 0.088 0.066 CID_66971611 | CID_66971611 | |
| 0.139 | 0.227 | 0.204 | DNA synthesis inhibitor | 0.204 0.117 CID_66971611 | CID_66971611 | |
| 0.159 | 0.261 | 0.224 | Antiobesity | 0.224 0.182 CID_66971611 | CID_66971611 | |
| 0.084 | 0.221 | 0.123 | Growth hormone agonist | 0.123 0.116 CID_66971611 | CID_66971611 | |
| 0.04 | 0.195 | 0.061 | Beta 2 adrenoreceptor agonist | 0.061 0.046 CID_66971611 | CID_66971611 | |
| 0.022 | 0.217 | 0.062 | Histidine decarboxylase inhibitor | 0.062 0.06 CID_66971611 | CID_66971611 | |
| 0.048 | 0.25 | 0.089 | Transcription factor NF kappa B stimulant | 0.089 0.053 CID_66971611 | CID_66971611 | |
| 0.072 | 0.397 | 0.175 | Hypoglycemic | 0.175 0.14 CID_66971611 | CID_66971611 | |
| 0.015 | 0.498 | 0.089 | Bronchodilator | 0.089 0.076 CID_66971611 | CID_66971611 | |
| 0.026 | 0.572 | 0.134 | MAP3K9 inhibitor | 0.134 0.087 CID_66971611 | CID_66971611 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |